Phytochemicals Target Multiple Metabolic Pathways in Cancer
Open Access
- 17 November 2023
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 12 (11) , 2012
Abstract
Cancer metabolic reprogramming is a complex process that provides malignant cells with selective advantages to grow and propagate in the hostile environment created by the immune surveillance of the human organism. This process underpins cancer proliferation, invasion, antioxidant defense, and resistance to anticancer immunity and therapeutics. Perhaps not surprisingly, metabolic rewiring is considered to be one of the “Hallmarks of cancer”. Notably, this process often comprises various complementary and overlapping pathways. Today, it is well known that highly selective inhibition of only one of the pathways in a tumor cell often leads to a limited response and, subsequently, to the emergence of resistance. Therefore, to increase the overall effectiveness of antitumor drugs, it is advisable to use multitarget agents that can simultaneously suppress several key processes in the tumor cell. This review is focused on a group of plant-derived natural compounds that simultaneously target different pathways of cancer-associated metabolism, including aerobic glycolysis, respiration, glutaminolysis, one-carbon metabolism, de novo lipogenesis, and β-oxidation of fatty acids. We discuss only those compounds that display inhibitory activity against several metabolic pathways as well as a number of important signaling pathways in cancer. Information about their pharmacokinetics in animals and humans is also presented. Taken together, a number of known plant-derived compounds may target multiple metabolic and signaling pathways in various malignancies, something that bears great potential for the further improvement of antineoplastic therapy.Keywords
Funding Information
- RSF (#21-75-10138, #2012022FD4119)
- Nazarbayev University (Kazakhstan) (#21-75-10138, #2012022FD4119)
This publication has 396 references indexed in Scilit:
- Glutamine‐driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxiaMolecular Systems Biology, 2013
- Phosphofructokinase 1 Glycosylation Regulates Cell Growth and MetabolismScience, 2012
- Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cellsCancer Cell International, 2012
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancerBMC Cancer, 2012
- Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferationProceedings of the National Academy of Sciences, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-FAK signaling pathways-A proteomic approachProteome Science, 2011
- 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletionCancer Chemotherapy and Pharmacology, 2010
- Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in miceFood and Chemical Toxicology, 2010
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009